Will TB-500 become legal? The PCAC review

By The Docket DeskResearched & sourcedUpdated 24 Jul 2026

The short answer

The FDA’s Pharmacy Compounding Advisory Committee reviews TB-500 on July 23, 2026. It is currently not FDA-approved and not legal to compound; the vote is the first formal step toward potential legal compounding.

FDA approvalNot approved

Compounding statusRemoved from Category 2 (Apr 2026, nominations withdrawn) · not on Category 1 — compounding not authorized

PCAC recommendationRecommended for compounding (Jul 23, 2026) — advisory only; FDA rulemaking required

Use under reviewWound healing

Earliest pharmacy accessLate 2026–Q1 2027 (if cleared)

A committee “yes” is a recommendation, not legalization. The path has two stages: first the PCAC vote, then formal FDA rulemaking. Each peptide effectively turns on both — which is why a favorable vote still doesn’t mean you can fill a prescription the next day.

What happened on July 23

The FDA’s Pharmacy Compounding Advisory Committee heard the evidence and voted to recommend adding TB-500 to the 503A list for wound healing. That vote is advisory only; the FDA must still issue a final rule before any pharmacy could legally compound it. Realistic patient access, if it happens at all, is late 2026 to early 2027.

Will TB-500 become legal in 2026?+

Not automatically. The committee voted to recommend it on July 23, 2026, but that vote is advisory only — the FDA must still issue a final rule, which typically takes months. Realistic legal compounded access is late 2026 to Q1 2027, and only if both steps go through.

Is “research-grade” TB-500 the same as a medicine?+

No. Material sold “for research use only” is not made or tested to pharmaceutical standards, is not authorized for human use, and carries no guarantee of identity, purity or sterility. This site does not link to or evaluate these sellers.

Primary sources: FDA 503A interim list (Category 2, 2023) · FDA Advisory Committee Calendar; Federal Register docket FDA-2025-N-6895.

Medical & editorial disclaimer. This article is independent reference information, not medical advice and not a recommendation to use any substance. TB-500 is not FDA-approved. Nothing here should be used to obtain, prepare, or self-administer any drug. Talk to a licensed clinician about your health. Peptide Docket is not affiliated with the FDA and does not sell peptides.